Liver Steatosis and Dyslipidemia After HCV Eradication by Direct Acting Antiviral Agents Are Synergistic Risks of Atherosclerosis
PLoS ONE - United States
doi 10.1371/journal.pone.0209615
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 21, 2018
Authors
Publisher
Public Library of Science (PLoS)